What was hot in 2016? And what should pharma's priorities lie in 2017?

Could public health suffer if the pharma industry doesn’t learn to win back trust?

What do ISPE’s 2016 Facility of the Year Awards tell us about the future direction of the industry?

The Medicine Maker Innovation Awards are back for the second year to show case the top tech of 2016.

A storm around drug pricing is building for 2017, but it shouldn’t overshadow the great and good.

What impact will Brexit, a new US President, and a flood of new technologies have on the industry?

Bioterrorism concerns prompt the UK government to fund development of a vaccine for plague.

Genentech’s Cell Culture Biologics Drug Substance Plant 2 in Vacaville, California.

A consortium of vendors and pharma companies search for a single, serialization standard.

Why has Médecins Sans Frontières rejected an offer of free vaccines from Pfizer?